创金合信全球医药生物股票发起(QDII)A(018155)持股变动
| 序号 |
股票代码 |
股票简称 |
变动数量(股) |
变动市值(元) |
变动类型 |
| 1 |
SMMT |
Summit Therapeutics Inc |
101,501.00 |
13,316,101.33 |
新增 |
| 2 |
CELC |
Celcuity LLC |
12,886.00 |
10,177,109.15 |
新增 |
| 3 |
PTGX |
Protagonist Therapeutics Inc |
13,206.00 |
9,631,198.66 |
新增 |
| 4 |
BNTX |
BioNTech SE ADR |
15,194.00 |
9,344,253.36 |
新增 |
| 5 |
NAMS |
NewAmsterdam Pharma Co NV |
41,708.00 |
9,237,904.67 |
新增 |
| 6 |
COGT |
Cogent Biosciences Inc |
31,577.00 |
8,409,829.97 |
新增 |
| 7 |
ABVX |
Abivax SA ADR |
9,720.00 |
7,489,018.85 |
新增 |
| 8 |
NKTR |
内克塔治疗 |
-55,564.00 |
-12,742,934.97 |
减仓 |
| 9 |
ANAB |
AnaptysBio Inc |
-64,399.00 |
-20,635,158.91 |
减仓 |
| 10 |
EWTX |
Edgewise Therapeutics Inc |
-176,548.00 |
-28,090,784.27 |
减仓 |
微信公众号
证券之星APP
基本资料
